Internal Medicine, Endocrinology, Diabetes, & Metabolism · Macon, GA
NPI
1659555134
Since 2007
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
265 Sheraton Blvd
Macon, GA, 31210
Phone (478) 746-8626
Groups this clinician bills Medicare through
Medicare paid, 2024
$98K
8,476 services
Medicare patients, 2024
512
Average age 72
Drug cost, 2024
$2.6M
5,270 prescriptions
Company payments, 2025
$67K
From 28 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Barry R Johns was code 99214 (office e&m - established), 576 times for 365 patients. In total Barry R Johns billed 8,476 services in 42 codes, and Medicare paid $98K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2010-07-13.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 576 | 365 | $78.78 | $45K |
| 84443 Clinical Chemistry | Office | 404 | 287 | $16.36 | $6,611 |
| 84550 Clinical Chemistry | Office | 353 | 257 | $4.38 | $1,546 |
| 80053 Clinical Chemistry | Office | 348 | 254 | $10.30 | $3,584 |
| 83036 Blood Count | Office | 230 | 172 | $9.38 | $2,158 |
| 80061 Clinical Chemistry | Office | 201 | 141 | $12.86 | $2,584 |
| 82570 Clinical Chemistry | Office | 165 | 115 | $4.96 | $818 |
| 82043 Clinical Chemistry | Office | 165 | 115 | $5.52 | $911 |
| 84439 Clinical Chemistry | Office | 160 | 119 | $8.73 | $1,396 |
| 82962 Clinical Chemistry | Office | 125 | 113 | $3.16 | $395 |
| 85025 Blood Count | Office | 109 | 83 | $7.61 | $830 |
| 99213 Office E&M - Established | Office | 108 | 103 | $54.45 | $5,881 |
| 82306 Clinical Chemistry | Office | 105 | 85 | $29.01 | $3,046 |
| 95251 Test - Miscellaneous | Office | 96 | 65 | $21.89 | $2,102 |
| 76536 Ultrasound - Nonspecific | Office | 83 | 81 | $70.35 | $5,839 |
By year: 2022 $92K for 11,284 services; 2023 $89K for 8,545 services; 2024 $98K for 8,476 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 84443 Clinical Chemistry | 404 | 287 | $16.36 | $6,611 |
| 84550 Clinical Chemistry | 353 | 257 | $4.38 | $1,546 |
| 80053 Clinical Chemistry | 348 | 254 | $10.30 | $3,584 |
| 83036 Blood Count | 230 | 172 | $9.38 | $2,158 |
| 80061 Clinical Chemistry | 201 | 141 | $12.86 | $2,584 |
| 82043 Clinical Chemistry | 165 | 115 | $5.52 | $911 |
| 82570 Clinical Chemistry | 165 | 115 | $4.96 | $818 |
| 84439 Clinical Chemistry | 160 | 119 | $8.73 | $1,396 |
| 82962 Clinical Chemistry | 125 | 113 | $3.16 | $395 |
| 85025 Blood Count | 109 | 83 | $7.61 | $830 |
Medicare prescription drug claims, 2024
In 2024, the drug Barry R Johns prescribed most often to Medicare patients was Levothyroxine Sodium, with 469 prescriptions and refills. In total Barry R Johns wrote 5,270 Medicare prescriptions that cost $2.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 469 | 1,157 | 130 | $5,695 |
| Ozempic Semaglutide | 453 | 734 | 99 | $704K |
| Synthroid Levothyroxine Sodium | 244 | 473 | 50 | $23K |
| Jardiance Empagliflozin | 215 | 446 | 64 | $259K |
| Mounjaro Tirzepatide | 204 | 254 | 39 | $268K |
| Atorvastatin Calcium Generic | 176 | 521 | 63 | $1,740 |
| Testosterone Cypionate Generic | 156 | 314 | 56 | $6,750 |
| Rosuvastatin Calcium Generic | 151 | 419 | 53 | $1,570 |
| Pregabalin Generic | 132 | 288 | 39 | $5,482 |
| Tresiba Flextouch U-100 Insulin Degludec | 125 | 312 | 42 | $80K |
| Metformin Hcl Er Metformin Hcl | 114 | 330 | 40 | $1,397 |
| Metformin Hcl Generic | 99 | 272 | 31 | $1,007 |
| Hydrocortisone Generic | 91 | 204 | 25 | $3,339 |
| Ezetimibe Generic | 89 | 208 | 26 | $2,062 |
| Methimazole Generic | 87 | 172 | 21 | $847 |
Brand drugs: 2,673 claims; generic drugs: 2,252 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Barry R Johns $67K ($67K in general payments such as food, travel and fees) from 28 companies. The largest payer was Novo Nordisk Inc with $50K.
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc NVO | 61 | $50K |
| Kyowa Kirin, Inc. 4151.T | 14 | $6,976 |
| Lilly USA, LLC LLY | 22 | $6,358 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 11 | $1,980 |
| Amgen Inc. AMGN | 19 | $461 |
| Insulet Corporation PODD | 9 | $203 |
| Sanofi-Aventis U.S. LLC SNY | 7 | $161 |
| Corcept Therapeutics CORT | 7 | $136 |
| Novartis Pharmaceuticals Corporation NVS | 7 | $124 |
| CeQur Corporation | 1 | $106 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.